Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
P1.01 - Advanced NSCLC
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P1.01-040 - Clinical Utility of Plasma-Based NGS for Advanced-Stage NSCLC Patients with Insufficient or Unavailable Tumor Tissue
09:30 - 09:30 | Presenter: Pilar Garrido | Author(s): J. Zugazagoitia, A. Gómez Rueda, S. Ponce, I. Ramos, C. Camps, D. Isla, Ó. Juan, Rosario García Campelo, J. De Castro, M. Trigo, E. Jantus-Lewintre, M. Palka, Luis Paz-Ares
- Abstract
Loading...
-
+
P1.04 - Clinical Design, Statistics and Clinical Trials
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Clinical Design, Statistics and Clinical Trials
-
+
P1.04-001 - Osimertinib with Ramucirumab or Necitumumab in Advanced T790M-positive EGFR-Mutant NSCLC: Preliminary Ph1 Study Results
09:30 - 09:30 | Presenter: Helena Yu | Author(s): David Planchard, James Chih-Hsin Yang, K.H. Lee, Pilar Garrido, Keunchil Park, Joo-Hang Kim, Dae Ho Lee, S. He, K. Wolff, B.H. Chao, Luis Paz-Ares
- Abstract
Loading...
-
+
MA 02 - Emerging Targets
- 11:00 - 12:30
- 10/16/2017
- Location: Room 511 + 512
- Type: Mini Oral
- Track: Clinical Design, Statistics and Clinical Trials
- Moderators:Ravi Salgia, Shun Lu
-
+
MA 02.02 - Phase 2 Study of Pembrolizumab Plus CC-486 vs Pembrolizumab Plus Placebo in Previously Treated Patients with Advanced NSCLC
11:05 - 11:10 | Presenter: Luis Paz-Ares | Author(s): B.P. Levy, Giuseppe Giaccone, Benjamin Besse, Enriqueta Felip, Marina Chiara Garassino, M. Domine, Pilar Garrido, B. Piperdi, S. Ponce Aix, R. Slepetis, X. Wu, A. Fandi
- Abstract
Loading...
-
+
P2.07 - Immunology and Immunotherapy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Immunology and Immunotherapy
-
+
P2.07-060 - Response Assessment and Subgroups Analysis According to the Lung Immune Prognostic Index (LIPI) for Immunotherapy in Advanced NSCLC Patients
09:30 - 09:30 | Presenter: Laura Mezquita | Author(s): E. Auclin, Roberto Ferrara, C. Caramella, M. Charrier, J. Remon, David Planchard, S. Ponce, Luis Paz-Ares, J. Lahmar, L. Leroy, C. Audigier-Valette, J. Zeron-Medina, Pilar Garrido, G. Zalcman, Julien Mazieres, J. Adam, N. Chaput, J. Soria, Benjamin Besse
- Abstract
Loading...
-
+
MA 15 - Lung Cancer Biology II
- 15:45 - 17:30
- 10/17/2017
- Location: Room 501
- Type: Mini Oral
- Track: Biology/Pathology
- Moderators:H. Akita
-
+
MA 15.01 - LungBEAM: A Prospective Multicenter Trial to Monitor EGFR Mutations Using BEAMing Technology in Stage IV NSCLC Patients
15:45 - 15:50 | Presenter: Pilar Garrido | Author(s): Enriqueta Felip, Luis Paz-Ares, Margarita Majem, T. Morán, J. Bosch, M. Trigo, Rosario García Campelo, J.L. González-Larriba, José Miguel Sánchez-Torres, D. Isla, N. Viñolas, C. Camps, A. Insa, Ó. Juan, Bartomeu Massuti, A. Paredes, Angel Artal Cortes, M. López-Brea, J. Palacios
- Abstract
Loading...